puromycin aminonucleoside has been researched along with Weight Gain in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fogo, AB; Jha, S; Ledbetter, S; Ling, H; Ma, LJ; Pozzi, A | 1 |
Egashira, Y; Nagaki, S; Sanada, H | 1 |
Chan, JC; Chan, W; Futterweit, S; Ma, C; Maesaka, J; Trachtman, H; Valderrama, E | 1 |
3 other study(ies) available for puromycin aminonucleoside and Weight Gain
Article | Year |
---|---|
Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies; Collagen; Creatinine; Dose-Response Relationship, Immunologic; Gene Expression; Glomerulosclerosis, Focal Segmental; Immunotherapy; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Plasminogen Activator Inhibitor 1; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Weight Gain | 2004 |
Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis.
Topics: Animals; Carboxy-Lyases; Kidney; Liver; Male; NAD; Nephrosis; Niacin; Niacinamide; Puromycin Aminonucleoside; Rats; Rats, Wistar; Serum Albumin; Tryptophan; Weight Gain | 2006 |
The effect of recombinant human insulin-like growth factor-I on chronic puromycin aminonucleoside nephropathy in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Chronic Disease; Disease Models, Animal; Humans; Insulin; Insulin-Like Growth Factor I; Kidney Diseases; Kidney Glomerulus; Male; Malondialdehyde; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Recombinant Proteins; Weight Gain | 1996 |